Applied BioCode Corporation
TAI: 6598.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Winston Z.
- Employees
- 43
- Headquarters
- Santa Fe Springs, United States
- IPO year
- 2017
- Market cap
- NT$2.3B
- Website
- https://www.apbiocode.com
Loading 6598…
Loading profile data…Frequently asked questions about 6598
What does Applied BioCode Corporation (6598.TW) do?
Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex diagnostic testing products for the In-Vitro diagnostics market. The company's products include the BioCode MDx 3000 system, an automated molecular diagnostic system that automates the PCR amplification, hybridization, and detection steps of molecular testi...
Where does 6598.TW trade?
Applied BioCode Corporation (6598.TW) trades on the Taiwan Stock Exchange.
What sector is 6598.TW in?
Applied BioCode Corporation (6598.TW) operates in the Healthcare sector, specifically in the Medical - Devices industry.
Who is the CEO of Applied BioCode Corporation?
Winston Z. is the chief executive officer of Applied BioCode Corporation (6598.TW).
Where is Applied BioCode Corporation headquartered?
Applied BioCode Corporation is headquartered in United States.
Does 6598.TW pay a dividend?
Applied BioCode Corporation (6598.TW) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 6598.TW go public?
Applied BioCode Corporation (6598.TW) completed its initial public offering in 2017.